APA (7th ed.) Citation

A, S., M, S., C, G., PLM, Z., PKJD, D. J., A, d. G., . . . JPC, G. (2026). Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: An early health-economic evaluation in the Netherlands. Cytotherapy, 28(7), 102822. https://doi.org/10.1016/j.jcyt.2026.102822

Chicago Style (17th ed.) Citation

A, Seyahian, et al. "Chimeric Antigen Receptor-natural Killer Cell Therapy in First-relapse Epithelial Ovarian Cancer: An Early Health-economic Evaluation in the Netherlands." Cytotherapy 28, no. 7 (2026): 102822. https://doi.org/10.1016/j.jcyt.2026.102822.

MLA (9th ed.) Citation

A, Seyahian, et al. "Chimeric Antigen Receptor-natural Killer Cell Therapy in First-relapse Epithelial Ovarian Cancer: An Early Health-economic Evaluation in the Netherlands." Cytotherapy, vol. 28, no. 7, 2026, p. 102822, https://doi.org/10.1016/j.jcyt.2026.102822.